Hexaminolevulinate-guided transurethral resection of non-muscle-invasive bladder cancer does not reduce the recurrence rates after a 2-year follow-up: a prospective randomized trial

2014

Purpose To assess the impact of hexaminolevulinate (HAL) on the long-term recurrence rate of NMIBC.

Keywords:

References

Citations